Did you know that The Princess Alexandra Hospital in Woolloongabba launched a pioneering clinical trial for advanced prostate cancer, offering new hope through Targeted Alpha Therapy that attacks cancer cells while preserving healthy tissues?
A New Weapon Against Cancer
Traditional oncology treatments, while effective, can have harsh side effects due to their impact on surrounding healthy cells. Targeted alpha therapy takes a different approach. It utilises radioactive isotopes that bind directly to cancer cells, delivering a potent dose of radiation with minimal damage to healthy organs.
Leading the Charge in Theranostics
PA Hospital’s Integrated Theranostic Centre, established in 2023, is one of the few facilities in Australia offering this cutting-edge treatment. Theranostics combines diagnostic imaging with targeted therapy, allowing doctors to precisely locate and eliminate cancer cells.
Hope for the Future
The TheraPb clinical trial for prostate cancer is just the beginning. This three-year study aims to enrol up to 100 patients and paves the way for further theranostic trials targeting various cancers.
PA Hospital Medical Oncologist Dr. Aaron Hansen emphasises the potential of theranostics to improve cancer treatment across various types of the disease.
This pioneering trial at PA Hospital signifies a significant advancement in cancer treatment. Targeted alpha therapy offers a potential future with fewer side effects and more effective cancer management.
Queensland Investment in Cancer Care
The Queensland Government is heavily invested in improving cancer care for its residents. Their 10-year Research Strategy, funded for $73 million, directly supports innovative research like the one at PA Hospital.
Additionally, the government’s 10-year Queensland Cancer Plan consultation survey, which ended 17 April 2024, sought public input to shape the future of cancer treatment in the state.
Minister for Health Shannon Fentiman applauds Queensland’s world-class research and highlights the importance of public participation in shaping the new Cancer Plan.
Published Date 17-April-2024
